Takeda auctions off a $670M portfolio of drugs and manufacturing ops, getting closer to its $10B goal
Takeda is $670 million closer to its goal of selling off $10 billion in assets to help pay for the Shire buyout.
The pharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
